Free Radic Biol Med 131 , 282298, (2018)
The primary outcome measures the proportion of participants achieving clinical remission at Week 24 using mMS criteria, while secondary outcomes include clinical response rates, symptomatic remission, histologic-endoscopic healing, and safety parameters assessed through Week 52 with an optional open-label extension
In clinical trials, retatrutide was generally introduced with a low starting dose and increased gradually over time
He is wearing sneakers, white Mavericks joggers, and a well-worn white T-shirt with a logo and TRACKS RECORDS, BLOOMINGTON, in emblazoned over one pec
Interestingly, new formulations under development (like the 7.2 mg version) show comparable outcomes to Mounjaro in newer studies
When Will You Start Losing Weight on GLP-1 Medications